CD40 and melanoma: Together, our data indicate that IDO1 is mainly expressed in tumor endothelial cells of B16-F10 and HCmel12 melanomas and that its expression can be further enhanced by agonistic CD40 mAb therapy and the associated IFNγ expression in the tumor microenvironment.